Goldman Sachs Crushes Value and Turnaround Hopes of Gilead Sciences
Goldman Sachs has muted any upside view by downgrading Gilead Sciences to Sell and lowering its price target.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 100
Is This Kezar Life Sciences Lupus Study in Trouble?
Kezar Life Sciences shares were absolutely crushed on Tuesday after the firm revealed data from its midstage trial in patients with systemic lupus erythematosus.
Big Pharma Short Sellers Hike Their Bets
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Major Biotechs See a Rising Tide in Short Interest
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Bad Diet Could Be to Blame for a Surprisingly High Share of Cancer Cases
New research discusses links between diet and cancer risk for Americans.
Citigroup Sees Big Upside for 2 of the Largest Biotechs
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
How Tonix Pharma Is Kicking Cocaine
Tonix Pharmaceuticals shares jumped on Thursday after the firm announced that it has in-licensed a Phase 2 asset, TNX-1300 for the treatment of cocaine intoxication.
How Eli Lilly Is Making Insulin More Affordable
Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use its rapid-acting insulin and need a lower-cost option.
Why Ocular Therapeutix Fell Short in Its Glaucoma Study
Ocular Therapeutix shares took a beating on Tuesday after the firm announced late-stage results for patients with primary open-angle glaucoma or ocular hypertension. These results come from the Phase 3 clinical trial of OTX-TP,…
Why BioCryst’s HAE Treatment Failed to Impress
BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema patients.
We May Have Been Wrong About the Connection Between Coffee and Poop for Years
New research indicates that caffeine may not be the reason that some coffee drinkers feel a need for a bowel movement after their morning coffee.
Thursday’s Top 4 ASCO Movers
This is known as the world’s largest clinical cancer conference, and it always delivers new results on clinical trials and updated treatments in the field. Not to mention, this conference has the potential to…
Can Danaher Walk Away From the Buyout of GE’s Biopharma Unit?
If there is one former Dow Jones industrial average leader that is in need of serious help, look no further than General Electric.
Solid Breast Cancer Results From MacroGenics Ahead of ASCO
MacroGenics announced additional details of the results from the Phase 3 Sophia study of margetuximab in patients with HER2-positive metastatic breast cancer who have previously been treated with anti-HER2-targeted therapies.
These Are the Most Used Drugs in the World — And Opioids Aren’t Even in the Top 5
About 53 million people worldwide use opioids or their natural counterparts and nearly half of them develop substance-abuse disorders leading to about 118,000 overdose deaths every year, According to the World Health Organization. More…